ArticlemedRxiv : the preprint server for health sciences2020

First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia.

Zelalem Temesgen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.